FORWARD FEATURES CALENDAR

Venture Capital

UpWest Labs, Singulariteam and OurCrowd most active Israeli VC Funds in 2016

UpWest Labs, Singulariteam and OurCrowd Funds were the most active venture capital funds in Israel during 2016, according to a report from IVC Research Center, in cooperation with Israeli law firm APM & Co. All three completed eight first investments in 2016, and while considered early stage, low-placement, small funds,

VCT fundraising up 53 per cent year-on-year

There is continued confidence in the venture capital trust (VCT) sector with fundraising for the 2016/17 tax year to 31 December 2016 up 53 per cent on fundraising to 31 December in the 2015/16 tax year, according to data published by the Association of Investment Companies (AIC). Some GBP169.5 million

Law firm Howard Kennedy dominates 2016/17 VCT market

Law firm Howard Kennedy has reaffirmed its market leading position in the UK venture capital trust (VCT) market, acting for 14 of the 18 VCTs coming to market in the 2016/17 financial year. The 14 funds advised by the firm are collectively seeking to raise GBP309 million, with all 18

VC investors to meet Swiss high-tech start-ups at Investor Summit 2017

Switzerland’s annual Investor Summit 2017 will give 180 international investors from VC firms such as KKR and Robert Bosch Venture Capital and international groups such as Credit Suisse, UBS and Swisscom to meet some of the country’s most promising high-growth tech start-ups tackling serious social, biological and commercial issues. Hosted

Buzzoole raises USD830,000 for influencer marketing platform

Influencer marketing platform Buzzoole has raised USD830,000 through a convertible note funding, led by international venture fund Impulse VC with co-investment from Swiss technology venture firm R301 Capital. The investment has potential to double within 18 months (up to USD1.6 million) and draw further investors.   Buzzoole’s proprietary, big data-based

Drug access platform myTomorrows raises EUR10m

Founded to facilitate access to drugs in development for physicians and their patients, myTomorrows has closed a EUR10 million growth funding round co-led by EQT Ventures and Octopus Ventures, with participation from existing investors Balderton Capital and Sofinnova Partners. Former GlaxoSmithKline chief medical officer James Shannon has also been appointed

Versant Ventures closes sixth healthcare fund

Versant Ventures has closed its newest fund, Versant Venture Capital VI, at its hard cap of CAD538 million (USD400 million). Versant will use its diversified global investment strategy to find, form and fund innovative healthcare companies with an emphasis on novel therapeutics.   Fund VI was highly oversubscribed and was

Sovereign wealth funds move to private markets and emerging markets

Two new white papers from State Street Corporation and the International Forum of Sovereign Wealth Funds (IFSWF) reveal changes in asset allocation among sovereign wealth funds (SWFs) over the past three to five years. The studies reveal shifts that include a significant increase in allocations to private markets (private equity,

Maven Capital Partners launches VCT fundraising

Venture capital trust (VCT) and private equity manager Maven Capital Partners’ Maven Income and Growth VCT 6 has launched a new VCT offer, which is limited to GBP6 million in new subscriptions.  There continues to be strong investor demand for the tax-free income potential and up to 30 per cent initial tax

US PE and VC funds rebounded from weak Q1

Private equity (PE) and venture capital (VC) funds in the US showed stronger performance in the second quarter of 2016 than the first, according to Cambridge Associates. Energy investments helped generate the rebound for the PE benchmark, and returns from healthcare VC investments made the biggest leap from the first

Events

12 November, 2026 – 5:00 pm

Directory Listings